Stay at the forefront of endocrinology with ENDO 2024 Session Recordings. Access over 140 sessions covering all facets of hormone health and science. Recordings include Plenaries, Meet the Professor sessions, Symposia, Professional Development Workshops, and more! Earn up to 145.25 AMA PRA Category 1 Credits™ while you learn at your own pace and from anywhere.
Combination therapy of SLGT2 inhibitors and GLP-1RAs was associated with superior cardiorenal benefits to monotherapy in type 2 diabetes.
Radioiodine therapy was non-inferior to no radioiodine therapy after thyroidectomy among patients with low-risk differentiated thyroid cancer.
In this Review, we aim to complement the 2023 update of the guidelines of the International Working Group on the Diabetic Foot. We highlight the…
On-Demand Education: Science from The Obesity Society The Obesity Society (TOS) on-demand education is a great way to gain an in-depth understanding of essential aspects…
A key mission of the Society is to foster the next generation of endocrine clinicians, researchers, and educators. To this end, the organization offers many…
Osteopenia was originally a qualitative term denoting bone that appeared to be less dense on radiographs. Since 1994, it has also had the quantitative meaning…
We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits…
Technological advances have profoundly affected people living with type 1 diabetes, their families or carers, and health-care systems. The innovations include the development of analogue…
